Odogwu et al., 2021 - Google Patents
Lactobacillus crispatus thrives in pregnancy hormonal milieu in a Nigerian patient cohortOdogwu et al., 2021
View HTML- Document ID
- 4644301911924282406
- Author
- Odogwu N
- Onebunne C
- Chen J
- Ayeni F
- Walther-Antonio M
- Olayemi O
- Chia N
- Omigbodun A
- Publication year
- Publication venue
- Scientific reports
External Links
Snippet
Steroid hormones are one of the presumed modulators of Lactobacillus abundance in the vaginal epithelium. We set out to characterize the vaginal microbiome (VMB) and also provide an in-depth understanding of the relative contribution of estradiol (E2) and …
- 230000035935 pregnancy 0 title abstract description 110
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Elovitz et al. | Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery | |
Chan et al. | Microbial-driven preterm labour involves crosstalk between the innate and adaptive immune response | |
Hong et al. | Association between polycystic ovary syndrome and the vaginal microbiome: a case‐control study | |
Huang et al. | Homogeneity of the vaginal microbiome at the cervix, posterior fornix, and vaginal canal in pregnant Chinese women | |
Nunn et al. | Changes in the vaginal microbiome during the pregnancy to postpartum transition | |
Haahr et al. | Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients | |
Haahr et al. | Vaginal microbiota and in vitro fertilization outcomes: development of a simple diagnostic tool to predict patients at risk of a poor reproductive outcome | |
Odogwu et al. | Lactobacillus crispatus thrives in pregnancy hormonal milieu in a Nigerian patient cohort | |
Xiao et al. | Predictive value of the composition of the vaginal microbiota in bacterial vaginosis, a dynamic study to identify recurrence-related flora | |
Drell et al. | Characterization of the vaginal micro-and mycobiome in asymptomatic reproductive-age Estonian women | |
Del Vecchio et al. | Cell-free DNA methylation and transcriptomic signature prediction of pregnancies with adverse outcomes | |
Amegashie et al. | Relationship between nugent score and vaginal epithelial exfoliation | |
Baud et al. | Microbial diversity in the vaginal microbiota and its link to pregnancy outcomes | |
Virtanen et al. | Vaginal microbiota composition correlates between pap smear microscopy and next generation sequencing and associates to socioeconomic status | |
Verstraelen et al. | The vaginal microbiome: I. research development, lexicon, defining “normal” and the dynamics throughout women's lives | |
Kervinen et al. | Parity and gestational age are associated with vaginal microbiota composition in term and late term pregnancies | |
Liu et al. | An altered microbiota in the lower and upper female reproductive tract of women with recurrent spontaneous abortion | |
Seo et al. | High prevalence of leptotrichia amnionii, atopobium vaginae, sneathia sanguinegens, and factor 1 microbes and association of spontaneous abortion among Korean women | |
Zhang et al. | Variation of the vaginal microbiome during and after pregnancy in Chinese women | |
Witkin et al. | Influence of Lactobacillus crispatus, Lactobacillus iners and Gardnerella vaginalis on bacterial vaginal composition in pregnant women | |
Odogwu et al. | Predominance of Atopobium vaginae at midtrimester: a potential indicator of preterm birth risk in a Nigerian cohort | |
Vasundhara et al. | Vaginal & gut microbiota diversity in pregnant women with bacterial vaginosis & effect of oral probiotics: an exploratory study | |
Cobo et al. | Characterization of vaginal microbiota in women with preterm labor with intra-amniotic inflammation | |
Ng et al. | Large-scale characterisation of the pregnancy vaginal microbiome and sialidase activity in a low-risk Chinese population | |
Kunaseth et al. | Vaginal microbiome of women with adenomyosis: A case-control study |